{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:50:29Z","timestamp":1649098229397},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3968","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T22:04:24Z","timestamp":1439589864000},"page":"2061-2064","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Extranodal Marginal Zone Lymphoma with Macroglobulinemia and Mixed Cryoglobulinemia Developed in a Patient with Chronic Hepatitis C"],"prefix":"10.2169","volume":"54","author":[{"given":"Chisun","family":"Min","sequence":"first","affiliation":[{"name":"Internal Medicine, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takakazu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Koyamada","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadamu","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Hematology, St. Luke's International Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Isaacson PG, Chott A, Nakamura S, Müller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of musosa-associated lymphoid tissue (MALT lymphoma). In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al, Eds. IARC, Lyon, 2008: 214-217."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 111: 76-80, 2004.","DOI":"10.1002\/ijc.20021"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ferreri AJM, Viale E, Guidoboni M, et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 17: 769-772, 2006.","DOI":"10.1093\/annonc\/mdl027"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Arcaini L, Burcheri S, Rossi A, et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 18: 346-350, 2007.","DOI":"10.1093\/annonc\/mdl388"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Asatiani E, Cohen P, Ozdemirli M, Kessler CM, Mavromatis B, Cheson BD. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement. Am J Hematol 77: 144-146, 2004.","DOI":"10.1002\/ajh.20157"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wöhrer S, Streubel B, Bartsch R, Chott A, Raderer M. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cnacer Res 10: 7179-7181, 2004.","DOI":"10.1158\/1078-0432.CCR-04-0803"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lin P, Hao S, Handy BC, Bueso-Ramos CE, Medeiros LJ. Lymphoid neoplasms associated with IgM pareprotein. A study of 382 patients. Am J Clin Pathol 123: 200-205, 2005.","DOI":"10.1309\/2A0FL1HM5PN2510P"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pivetti S, Novarino A, Merico F, et al. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol 95: 204-211, 1996.","DOI":"10.1046\/j.1365-2141.1996.7542376.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ferri S, Muratori L, Lenzi M, Granito A, Bianchi FB, Vergani D. HCV and autoimmunity. Curr Pharmaceut Design 14: 1678-1685, 2008.","DOI":"10.2174\/138161208784746824"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vergani D, Mieli-Vergani G. Autoimmune manifestations in viral hepatitis. Semin Immunopathol 35: 73-85, 2013.","DOI":"10.1007\/s00281-012-0328-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ferri C, Antonelli A, Mascia MT, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Digest Liver Dis 39 (Suppl 1): S15-S21, 2007.","DOI":"10.1016\/S1590-8658(07)80005-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297: 2010-2017, 2007.","DOI":"10.1001\/jama.297.18.2010"},{"key":"13","unstructured":"13. Swerdlow SH, Berger F, Pileri SA, Harris NL, Jaffe ES, Stein H. Lymphoplasmacytic lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al, Eds. IARC, Lyon, 2008: 194-195."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Van Huyen JPD, Molina T, Delmer A, et al. Splenic marginal zone lymphoma with or withoug plasmacytic differentiation. Am J Surg Pathol 24: 1581-1592, 2000.","DOI":"10.1097\/00000478-200012000-00001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Berger F, Traverse-Glehen A, Felman P, et al. Clinicopathologic features of Waldenström's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma 5: 220-224, 2005.","DOI":"10.3816\/CLM.2005.n.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Thieblement C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95: 802-806, 2000.","DOI":"10.1182\/blood.V95.3.802.003k19_802_806"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa associated lymphoid tissue. Blood 101: 2489-2495, 2003.","DOI":"10.1182\/blood-2002-04-1279"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oh SY, Kim WS, Kim JS, et al. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and prognostic factors. Consortium for improving survival of lymphoma study. Int J Hematol 92: 510-517, 2010.","DOI":"10.1007\/s12185-010-0680-z"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. de Boer JP, Hiddink RF, Raderer M, et al. Dissemination pattern in non-gastric MALT lymphoma. Haematologica 93: 201-206, 2008.","DOI":"10.3324\/haematol.11835"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pangalis GA, Kyrtsonis MC, Kontopidou FN, et al. Differential diagnosis of Waldenstöm's macroglobulinemia and other B-cell disorders. Clin Lymphoma 5: 235-240, 2005.","DOI":"10.3816\/CLM.2005.n.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Valdez R, Finn WG, Ross CW, Singleton TP, Tworek JA, Schnitzer B. Waldenstöm macroglobulinemia caused by extranodal marginal zone B-cell lymphoma. A report of six cases. Am J Clin Pathol 116: 683-690, 2001.","DOI":"10.1309\/6WPX-66CM-KGRH-V4RW"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 15: 2078-2085, 2006.","DOI":"10.1158\/1055-9965.EPI-06-0308"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterol 125: 1723-1732, 2003.","DOI":"10.1053\/j.gastro.2003.09.025"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kelaidi C, Rollot F, Park S, et al. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia 18: 1711-1716, 2004.","DOI":"10.1038\/sj.leu.2403443"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 23: 468-473, 2005.","DOI":"10.1200\/JCO.2005.06.008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Svoboda J, Andreadis C, Downs LH, Miller WT Jr, Tsai DE, Schuster TJ. Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leuk Lymphoma 46: 1365-1368, 2005.","DOI":"10.1080\/104281905001028289"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int 76: 818-824, 2009.","DOI":"10.1038\/ki.2009.247"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinemias. Lancet 379: 348-360, 2012.","DOI":"10.1016\/S0140-6736(11)60242-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/16\/54_54.3968\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T06:44:05Z","timestamp":1599461045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/16\/54_54.3968\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":28,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3968","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}